- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22:10 | After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder | ||
| 21:10 | Abbott's stigma-busting campaign shows how diabetes biases lead to silence, skipped care | ||
| 18:10 | Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy | ||
| 18:10 | Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders | ||
| 18:10 | Once valued at $10B, bluebird bio sold to private equity firms for $29M | ||
| 17:10 | Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio | ||
| 16:10 | PMCPA brings the buzzkill to LinkedIn celebration, laying into GSK over employee's clicks | ||
| Do | A week after RFK Jr.'s confirmation, HHS postpones vaccine committee meeting | ||
| Do | Canada locks down an initial 500K doses of GSK's bird flu vaccine | ||
| Do | Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad | ||
| Do | Challenging powerhouse Pfizer, BridgeBio's launch of Attruby is off to a 'great start,' analyst says | ||
| Do | Merck, plaintiff agree to hit the brakes on Gardasil trial in California | ||
| Do | CDC's 'Wild to Mild' flu vaccine campaign muzzled amid HHS handover: report | ||
| Do | FDA hits pair of Indian API makers with warning letters, import alerts | ||
| Do | Genentech, Novartis join forces to raise awareness of food allergies' impact on families | ||
| Do | AstraZeneca pays $160M for Fibrogen's China unit, regional rights to roxadustat | ||
| Mi | Ionis marks 'milestone event' of Tryngolza launch with first campaigns targeting patients, HCPs | ||
| Mi | FDA disrupts Harmony's expansion dreams for excessive sleepiness drug Wakix with refusal letter | ||
| Mi | After high-profile pledge to secure confirmation, RFK Jr. now says panel will review childhood vaccine schedules | ||
| Mi | Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants | ||
| Mi | Bristol Myers Squibb notches overall survival win with Opdivo in pre-operative NSCLC | ||
| Mi | Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035 | ||
| Mi | Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet | ||
| Di | Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA | ||
| Di | As BMS-paired triplet misses survival mark in kidney cancer, Exelixis shifts focus elsewhere |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
